|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Elitek-rasburicase:an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas 显示文摘 | Navolanic PM Pui CH Larson RA | 2003 | Leukemia2003，17，3： | 1 |
| 2 | The mTOR pathway is regulated by polycystin-1,and its inhibition reverses renal cystogenesis in polycystic kidney disease显示文摘 | Murcia NS Larson CH | 2006 | Proc Natl Acad Sci U S A2006，103，14： | 1 |
| 3 | Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Rport, Dallas, Texas, January2002显示文摘 | Navolanic PM Pui CH Larson RA | 2003 | Leukemia2003，17，3： | 1 |
| 4 | The mTOR pathway is regulated by polycystin-1,and its inhibition reverses renal cystogenesis in polycystic kidney disease显示文摘 | Shillingford JM Murcia NS Larson CH | 2006 | Proc Natl Acad Sci2006，103，： | 1 |
| 5 | ElitekTM-rasburicase:an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome显示文摘 | Navolanic PM Pui CH Larson RA | 2003 | Leukemia2003，17，3： | 1 |
| 6 | The mTOR pathway is regulated by polycystin- 1, and its inhibition reverses renal eystogenesis in polycystic kidney disease显示文摘 | Shillingford JM Murcia NS Larson CH | 2006 | Proc Natl Acad Sci U S A2006，103，14： | 1 |
| 7 | Elitek - rasburicase:an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas,Texas 显示文摘 | Pui CH Larson RA | 2003 | Leukemia2003，17，3： | 1 |
| 8 | The mTOR pathway is regulated by polycystin-1,and its inhibition reverses renal cystogenesis in polycystic kidney disease显示文摘 | Shillingford JM Murcia NS Larson CH | 2006 | Proc Natl Acad Sci U S A2006，103，14： | 1 |
| 9 | The mTOR pathway is regulated by polycystin-1,and its inhibition reverses renal cystogenesis in polycystic kidney disease显示文摘 | Shillingford JM Murcia NS Larson CH | 2006 | Proc Natl Acad Sci USA2006，103，14： | 1 |
| 10 | Elitek-rasburicase:an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome,a Meeting Report,Dallas,Texas,January 2002显示文摘 | Navolanic PM Pui CH Larson RA | 2003 | Leukemia2003，17，3： | 1 |
| 11 | Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002显示文摘 | Larson RA Daley GQ Schiffer CA Porcu P Pui CH Marie JP | 2003 | Leukemia2003，17，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员